Alan Ashworth
CIK: 0001886426
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CTMX
CytomX Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Ashworth Alan
Ashworth Alan (SEC CIK 0001886426) files insider reports with the SEC as Director of CytomX Therapeutics, Inc. (CTMX).
Signal8 holds 2 ownership filings by Ashworth Alan, all Form 4s, filed between Jun 13, 2025 and Jun 22, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ashworth Alan's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Ashworth Alan
Other insiders filing for CytomX Therapeutics, Inc. (CTMX)
- McCarthy Sean A., CEO
- Carvajal Alejandra, Chief Legal Officer
- Fuchs Charles S., Director
- Su Zhen, Director
- Young Matthew P., Director
- Mohindru Mani, Director